The Influence of Patent Foramen Ovale on the Clinical Features of Migraine without Aura: A Cross-Sectional Study

References

• Ashina M, Katsarava Z, Do TP, et al. Migraine: epidemiology and systems of care. Lancet. 2021;397(10283):1485–1495. doi:10.1016/s0140-6736(20)32160-7
   PubMed Web of Science ®Google Scholar
• Ashina M, Ropper AH. Migraine. N Engl J Med. 2020;383(19):1866–1876. doi:10.1056/NEJMra1915327
   PubMed Web of Science ®Google Scholar
• Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259. doi:10.1016/s0140-6736(17)32154-2
   PubMed Web of Science ®Google Scholar
• Yao C, Wang Y, Wang L, et al. Burden of headache disorders in China, 1990–2017: findings from the Global Burden of Disease Study 2017. J Headache Pain. 2019;20(1):102. doi:10.1186/s10194-019-1048-2
   PubMed Web of Science ®Google Scholar
• Katsuki M, Matsumori Y, Kawahara J, et al. Headache education by leaflet distribution during COVID-19 vaccination and school-based on-demand e-learning: Itoigawa Geopark Headache Awareness Campaign. Headache. 2023;63(3):429–440. doi:10.1111/head.14472
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Hentz JG, Sahai-Srivastava S, et al. Headache characteristics and burden from chronic migraine with medication overuse headache: cross-sectional observations from the medication overuse treatment strategy trial. Headache. 2021;61(2):351–362. doi:10.1111/head.14056
   PubMed Web of Science ®Google Scholar
• Kumar P, Kijima Y, West BH, Tobis JM. The connection between patent foramen ovale and migraine. Neuroimaging Clin N Am. 2019;29(2):261–270. doi:10.1016/j.nic.2019.01.006
   PubMed Web of Science ®Google Scholar
• Zhao Q, Liu R, Zhou J, Dong Z, Chen Y. Prevalence and grade of RLS in migraine: a prospective study of 251 migraineurs by synchronous test of c-TTE and c-TCD. Medicine. 2021;100(4):e24175. doi:10.1097/md.0000000000024175
   PubMed Web of Science ®Google Scholar
• Hara H, Virmani R, Ladich E, et al. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol. 2005;46(9):1768–1776. doi:10.1016/j.jacc.2005.08.038
   PubMed Web of Science ®Google Scholar
• Guo Y, Shi Y, Zhu D, Liu R, Qi Y, Luo G. Clopidogrel can be an effective complementary prophylactic for drug-refractory migraine with patent foramen ovale. J Investig Med. 2020;68(7):1250–1255. doi:10.1136/jim-2020-001342
   PubMed Web of Science ®Google Scholar
• He Q, Zhang Y, Wang F, et al. Impact of right-to-left shunt and transcatheter closure on the clinical features of migraine. Int J Neurosci. 2020;130(3):270–275. doi:10.1080/00207454.2019.1672681
   PubMed Web of Science ®Google Scholar
• Qi Y, Zhang Y, Luo X, et al. Efficacy of patent foramen ovale closure for treating migraine: a prospective follow-up study. J Investig Med. 2021;69(1):7–12. doi:10.1136/jim-2020-001323
   PubMed Web of Science ®Google Scholar
• Merikangas KR. Contributions of epidemiology to our understanding of migraine. Headache. 2013;53(2):230–246. doi:10.1111/head.12038
   PubMed Web of Science ®Google Scholar
• Olesen J. Headache classification committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. doi:10.1177/0333102417738202
   Web of Science ®Google Scholar
• Zhang Y, Zhu X, Jiang S. Recommendations from Chinese experts on management of patients with patent foramen ovale. Chin Heart J. 2015;27:373–379.
   Google Scholar
• Carod-Artal FJ, da Silveira Ribeiro L, Braga H, Kummer W, Mesquita HM, Vargas AP. Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia. 2006;26(8):934–939. doi:10.1111/j.1468-2982.2006.01156.x
   PubMed Web of Science ®Google Scholar
• Dalla VG, Guindani M, Zavarise P, Griffini S, Pezzini A, Padovani A. Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain. 2005;6(4):328–330. doi:10.1007/s10194-005-0223-9
   PubMedGoogle Scholar
• Domitrz I, Mieszkowski J, Kamińska A. Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine. Headache. 2007;47(9):1311–1318. doi:10.1111/j.1526-4610.2006.00724.x
   PubMed Web of Science ®Google Scholar
• Tang Y, Peng A, Peng B, et al. Association between patent foramen ovale and migraine without aura: a community-based cross-sectional study in China. BMJ open. 2022;12(3):e056937. doi:10.1136/bmjopen-2021-056937
   PubMed Web of Science ®Google Scholar
• Wang SB, Liu KD, Yang Y, et al. Prevalence and extent of right-to-left shunt on contrast-enhanced transcranial Doppler in Chinese patients with migraine in a multicentre case-control study. Cephalalgia. 2018;38(4):690–696. doi:10.1177/0333102417708203
   PubMed Web of Science ®Google Scholar
• Liboni W, Molinari F, Allais GB, et al. Patent foramen ovale detected by near-infrared spectroscopy in patients suffering from migraine with aura. Neurol Sci. 2008;29(Suppl 1):S182–S185. doi:10.1007/s10072-008-0920-7
   PubMedGoogle Scholar
• Post MC, Luermans JG, Plokker HW, Budts W. Patent foramen ovale and migraine. Catheter Cardiovasc Interv. 2007;69(1):9–14. doi:10.1002/ccd.20931
   PubMed Web of Science ®Google Scholar
• Caputi L, Usai S, Carriero MR, et al. Microembolic air load during contrast-transcranial Doppler: a trigger for migraine with aura? Headache. 2010;50(8):1320–1327. doi:10.1111/j.1526-4610.2010.01621.x
   PubMed Web of Science ®Google Scholar
• Iwasaki A, Suzuki K, Takekawa H, et al. The relationship between right-to-left shunt and brain white matter lesions in Japanese patients with migraine: a single center study. J Headache Pain. 2017;18(1):3. doi:10.1186/s10194-016-0714-x
   PubMedGoogle Scholar
• Park HK, Lee SY, Kim SE, Yun CH, Kim SH. Small deep white matter lesions are associated with right-to-left shunts in migraineurs. J Neurol. 2011;258(3):427–433. doi:10.1007/s00415-010-5771-5
   PubMed Web of Science ®Google Scholar
• Wahl A, Praz F, Tai T, et al. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart. 2010;96(12):967–973. doi:10.1136/hrt.2009.181156
   PubMed Web of Science ®Google Scholar
• Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention WithSTARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117(11):1397–1404. doi:10.1161/circulationaha.107.727271
   PubMed Web of Science ®Google Scholar
• Tobis JM, Charles A, Silberstein SD, et al. Percutaneous closure of patent foramen ovale in patients with migraine: the PREMIUM trial. J Am Coll Cardiol. 2017;70(22):2766–2774. doi:10.1016/j.jacc.2017.09.1105
   PubMed Web of Science ®Google Scholar
• Mattle HP, Evers S, Hildick-Smith D, et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur Heart J. 2016;37(26):2029–2036. doi:10.1093/eurheartj/ehw027
   PubMed Web of Science ®Google Scholar
• Mahmoud AN, Mentias A, Elgendy AY, et al. Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open. 2018;8(3):e020498. doi:10.1136/bmjopen-2017-020498
   PubMed Web of Science ®Google Scholar
• Mojadidi MK, Kumar P, Mahmoud AN, et al. Pooled analysis of PFO occluder device trials in patients with PFO and migraine. J Am Coll Cardiol. 2021;77(6):667–676. doi:10.1016/j.jacc.2020.11.068
   PubMed Web of Science ®Google Scholar